TRACEY GRAPPE: Open Payments
NPI 1225077282 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 56 payments from 19 companies in 2025. Trend: 2023 $996 · 2024 $887 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $146 |
| GlaxoSmithKline, LLC. | 7 | $137 |
| Lilly USA, LLC | 7 | $103 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Novo Nordisk Inc | 4 | $84 |
| Sumitomo Pharma America, Inc. | 4 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $60 |
| PFIZER INC. | 2 | $49 |
| Exact Sciences Corporation | 3 | $45 |
| Currax Pharmaceuticals LLC | 2 | $34 |
Products named: Kerendia, MOUNJARO, SHINGRIX, GEMTESA, XIFAXAN, BREZTRI, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
